Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company.
A number of equities analysts have recently weighed in on RBGLY shares. Zacks Research downgraded Reckitt Benckiser Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Reckitt Benckiser Group in a research report on Tuesday, June 30th. Finally, Jefferies Financial Group upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Tuesday, July 21st.
Read Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 0.5%
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
